Cinnamaldehyde induces apoptosis and enhances anti‐colorectal cancer activity via covalent binding to HSPD1
Phytotherapy Research · 2024-10 · 38 (10) · 4957-4966
DOI: 10.1002/ptr.7840 ↗At a glance
Journal article in Phytotherapy Research, published online on 2023-04-22. Written by Weiyi Zhang and 5 co-authors. Institution: Key Laboratory of Active Components of Xinjiang Natural Medicine and Drug Release Technology (XJDX1713), School of Pharmacy, Xinjiang Medical Univers…. Major MEDLINE topics: Acrolein, Colorectal Neoplasms, Apoptosis, Proto-Oncogene Proteins c-akt. Cited 26 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Central Government Guided Local Special Funds for Scientific and Technological Development (Establishment and Application of High-throughput Screening System f…, Research Foundation of Xinjiang Medical University, Xinjiang Key Laboratory of Active Components of Natural Medicine and Drug Release Technology.
Abstract (original language)
Colorectal cancer (CRC) is a common malignant tumor with high morbidity and mortality rates worldwide. Although surgical resection and adjuvant radiotherapy/chemotherapy are the mainstays of CRC treatment, the efficacy is unsatisfactory due to several limitations, including high drug resistance. Accordingly, there is a dire need for new drugs or a novel combination approach to treat this patient population. Herein, we found that cinnamaldehyde (CA) could exert an antitumor effect in HCT‐116 cell lines. Target fishing, molecular imaging, and live‐cell tracing using an alkynyl–CA probe revealed that the heat shock 60 kDa protein 1 (HSPD1) protein was the target of CA. The covalent binding of CA with HSPD1 altered its stability. Furthermore, our results demonstrated that CA could induce cell apoptosis by inhibiting the PI3K/Akt signaling pathway and enhanced anti‐CRC activity both in vitro and in vivo. Meanwhile, CA combined with different chemotherapeutic agents was beneficial to patients resistant to anti‐CRC drug therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of Active Components of Xinjiang Natural Medicine and Drug Release Technology (XJDX1713), School of Pharmacy, Xinjiang Medical University, Urumchi, China.
- State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China.
ORCID profiles: Linlin Li
Funding
- Central Government Guided Local Special Funds for Scientific and Technological Development (Establishment and Application of High-throughput Screening System f…
- Research Foundation of Xinjiang Medical University
- Xinjiang Key Laboratory of Active Components of Natural Medicine and Drug Release Technology
Cite
APA
Zhang, W., Lei, W., Shen, F., Wang, M., Li, L., & Chang, J. (2024). Cinnamaldehyde induces apoptosis and enhances anti‐colorectal cancer activity via covalent binding to HSPD1. Phytotherapy Research, 38(10), 4957-4966. https://doi.org/10.1002/ptr.7840
Vancouver
Zhang W, Lei W, Shen F, Wang M, Li L, Chang J. Cinnamaldehyde induces apoptosis and enhances anti‐colorectal cancer activity via covalent binding to HSPD1. Phytotherapy Research. 2024;38(10):4957-4966. doi:10.1002/ptr.7840
BibTeX
@article{Zhang2024,
author = {Zhang, Weiyi and Lei, Wei and Shen, Fukui and Wang, Mukuo and Li, Linlin and Chang, Junmin},
title = {Cinnamaldehyde induces apoptosis and enhances anti‐colorectal cancer activity via covalent binding to HSPD1},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {10},
pages = {4957--4966},
doi = {10.1002/ptr.7840}
}
EUVIMED